Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells - PubMed (original) (raw)
. 1998 Apr 3;273(14):8225-31.
doi: 10.1074/jbc.273.14.8225.
Affiliations
- PMID: 9525928
- DOI: 10.1074/jbc.273.14.8225
Free article
Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells
Y Q Chen et al. J Biol Chem. 1998.
Free article
Abstract
This study was designed to characterize the direct effects of hyperglycemia on plasminogen activator inhibitor-1 (PAI-1) expression in cultured vascular smooth muscle cells. Glucose induced dose- and time-dependent increases of PAI-1 mRNA expression in rat aortic smooth muscle (RASM) cells in vitro. Using a series of luciferase reporter gene constructs containing PAI-1 5'-flanking sequence (from -6.4 kilobase to -42 base pairs (bp)) transfected into RASM, we found that glucose (25 mM) consistently induced a 4-fold increase in luciferase activity, with the response localized to sequence between -85 and -42 bp. Mutagenesis of two putative Sp1-binding sites located in the region of interest essentially obliterated the glucose-response. Electrophoretic mobility shift assays with radiolabeled oligonucleotides containing the two putative Sp1-binding sites from PAI-1 promoter and nuclear extracts from RASM cells revealed that glucose treatment markedly changed the mobility pattern of the major protein-DNA complexes. Supershift assay showed that transcription factor Sp1 was present in the complexes under control and hyperglycemic conditions. These results suggest that glucose regulates PAI-1 gene expression in RASM cells through an effect on two adjacent Sp1 sites located between -85 and -42 bp of the PAI-1 5'-flanking region and that the release of a transcriptional repressor from the Sp1 complexes may explain the activation of the PAI-1 gene under high glucose conditions in RASM cells.
Similar articles
- Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells.
Goldberg HJ, Scholey J, Fantus IG. Goldberg HJ, et al. Diabetes. 2000 May;49(5):863-71. doi: 10.2337/diabetes.49.5.863. Diabetes. 2000. PMID: 10905498 - Sp1-like activity mediates angiotensin-II-induced plasminogen-activator inhibitor type-1 (PAI-1) gene expression in mesangial cells.
Motojima M, Ando T, Yoshioka T. Motojima M, et al. Biochem J. 2000 Jul 15;349(Pt 2):435-41. doi: 10.1042/0264-6021:3490435. Biochem J. 2000. PMID: 10880342 Free PMC article. - The hexosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Sp1 transcriptional activation through protein kinase C-beta I and -delta.
Goldberg HJ, Whiteside CI, Fantus IG. Goldberg HJ, et al. J Biol Chem. 2002 Sep 13;277(37):33833-41. doi: 10.1074/jbc.M112331200. Epub 2002 Jul 8. J Biol Chem. 2002. PMID: 12105191 - Characterization of the rat connexin40 promoter: two Sp1/Sp3 binding sites contribute to transcriptional activation.
Bierhuizen MF, van Amersfoorth SC, Groenewegen WA, Vliex S, Jongsma HJ. Bierhuizen MF, et al. Cardiovasc Res. 2000 Jun;46(3):511-22. doi: 10.1016/s0008-6363(00)00041-9. Cardiovasc Res. 2000. PMID: 10912461 - Identification and localization of a fatty acid response region in the human plasminogen activator inhibitor-1 gene.
Chen Y, Billadello JJ, Schneider DJ. Chen Y, et al. Arterioscler Thromb Vasc Biol. 2000 Dec;20(12):2696-701. doi: 10.1161/01.atv.20.12.2696. Arterioscler Thromb Vasc Biol. 2000. PMID: 11116074
Cited by
- Diabetic Retinopathy: New Treatment Approaches Targeting Redox and Immune Mechanisms.
Tang Q, Buonfiglio F, Böhm EW, Zhang L, Pfeiffer N, Korb CA, Gericke A. Tang Q, et al. Antioxidants (Basel). 2024 May 12;13(5):594. doi: 10.3390/antiox13050594. Antioxidants (Basel). 2024. PMID: 38790699 Free PMC article. Review. - Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment.
Zhu J, Hu Z, Luo Y, Liu Y, Luo W, Du X, Luo Z, Hu J, Peng S. Zhu J, et al. Front Endocrinol (Lausanne). 2024 Jan 9;14:1265372. doi: 10.3389/fendo.2023.1265372. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38264279 Free PMC article. Review. - Circadian rhythm of plasminogen activator inhibitor-1 and cardiovascular complications in type 2 diabetes.
Yu Y, Li W, Xu L, Wang Y. Yu Y, et al. Front Endocrinol (Lausanne). 2023 Mar 20;14:1124353. doi: 10.3389/fendo.2023.1124353. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37020596 Free PMC article. Review. - Research Progress on Mitochondrial Dysfunction in Diabetic Retinopathy.
Wu Y, Zou H. Wu Y, et al. Antioxidants (Basel). 2022 Nov 15;11(11):2250. doi: 10.3390/antiox11112250. Antioxidants (Basel). 2022. PMID: 36421435 Free PMC article. Review. - PAI-1: A Major Player in the Vascular Dysfunction in Obstructive Sleep Apnea?
Badran M, Gozal D. Badran M, et al. Int J Mol Sci. 2022 May 15;23(10):5516. doi: 10.3390/ijms23105516. Int J Mol Sci. 2022. PMID: 35628326 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous